New UC San Diego Dissemination and Implementation Science Center provides researchers and practitioners with the training, technical assistance, mentoring and resources needed to implement their findings in real-world settings.
New UC San Diego Dissemination and Implementation Science Center provides researchers and practitioners with the training, technical assistance, mentoring and resources needed to implement their findings in real-world settings
The UCI Health Chao Family Comprehensive Cancer has launched a first-in-the-nation clinical trial combining two recently approved drugs to prevent recurrence of adult acute myeloid leukemia (AML) in patients with myelodysplastic changes or therapy-related AML. The investigator-initiated clinical trail led by oncologist Dr. Deepa Jeyakumar is adding the stem-cell drug…
Researchers at University of California San Diego School of Medicine are recruiting eligible children between the ages of seven and fourteen years for a Phase III clinical trial to determine whether cannabidiol (CBD) reduces severe behavior problems in children with autism spectrum disorder.
UC San Diego researchers recruiting participants, ages 7 to 14, to determine whether cannabidiol, an extract of cannabis, can reduce behavioral symptoms of severe autism spectrum disorder
Rebekah Charney, a postdoctoral researcher in the School of Medicine, has received a five-year “Pathway to Independence” grant from the National Institute of Dental and Craniofacial Research of the National Institutes of Health, or NIH.
Researchers at University of California San Diego School of Medicine and UC San Diego Health have launched a clinical trial to assess the safety and efficacy of convalescent plasma (CP) to prevent COVID-19 after a known exposure to the virus.
